Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing

Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform

TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing.

Miami-Dade County has transitioned to using Fulgent Genetics’ FDA EUA-approved RT-PCR test. Results will be delivered to patients within 24 to 48 hours. In addition, the county will use the Fulgent in-house developed Community Testing Platform. This is a complete solution for managing drive-through testing sites, including the patient visiting the Fulgent-Miami-Dade website to choose a location, make an appointment, and complete a questionnaire. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. Fulgent’s reporting solution will then deliver reports directly to patients’ mobile phones. This system also includes heat maps and contact tracing functionality. Miami-Dade joins a long list of counties to use Fulgent’s Community Testing Platform including, but not limited to Santa Clara County, San Bernardino County, Los Angeles County, City of Long Beach and Orange County.

“Miami-Dade residents now have improved access to reliable and fast COVID-19 testing. Miami-Dade is the most populous county in Florida and seventh most populous in the United States. We are incredibly happy to partner with the county in their tremendous efforts to combat this virus,” commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. “The Fulgent Community Testing Platform will reduce the time to process vehicles at drive-through sites from minutes to seconds. We believe the process is similar to buying coffee with a QR code on your cell phone; cars drive up, show their phone, scan the kit, self-administer the shallow nasal swab and drive off. This allows for many more appointments to be available with shorter wait times. After Fulgent receives the sample, results are available within 24 to 48 hours. We believe this combination of delivering the gold-standard RT-PCR test at scale, in timely fashion, combined with a management system that makes the process seamless for everyone, is key to a successful testing protocol,” Perthuis added.